Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

ICYMI: The Wall Street Journal Makes the Case for Sharing Truthful, Non-Misleading Information

By Mit Spears  |    August 18, 2015
On Friday, The Wall Street Journal editorialized on free speech in the context of sharing scientific and medical information, something critical for the U.S. Food and Drug Administration (FDA). ...   Read More

Legislative and Legal Action Seeks to Improve Communications with Health Care Professionals to Better Inform Patient Care

By Jeff Francer  |    August 3, 2015
July was an active time in healthcare policy, with promising policy developments on Capitol Hill and in the court system regarding the ability of biopharmaceutical companies to share up to date...   Read More

Biopharmaceutical Companies Recognized as Meaningful Places to Work

By John Tunnell  |    May 22, 2015
Loretta was diagnosed with Stage 4 lung cancer 12 years ago - but thanks to medical breakthroughs and innovative medicines, she is living a happy, active life today. Matt was given a five percent...   Read More

Week in Review: The Latest from PhRMA

By Mollymae Metheny  |    April 3, 2015
Communications with health care professionals, advances in cancer treatment documentary, importance of safe drug disposal and more Communications with Health Care Professionals – Mit Spears, Jeff...   Read More

Embracing 21st Century Information Sharing: Defining a New Paradigm for the FDA and Communications with Health Care Professionals

By Mit Spears  |    April 1, 2015
The Food and Drug Administration (FDA) protects public health by approving new medicines for patients, ensuring unsafe treatments are not used and monitoring the evolution of scientific insights...   Read More

Physicians Deserve Timely Authoritative Risk Information For Medicines

By Jeff Francer  |    March 11, 2015
A Washington Post article today inaccurately describes the Food and Drug Administration’s (FDA) proposed guidance on distributing peer-reviewed scientific and medical information to healthcare...   Read More

Biopharmaceutical Companies Face Restrictions in Sharing Scientific Information to Improve Patient Care

By Mit Spears  |    October 29, 2013
Yesterday, I had the opportunity to speak at a conference of regulatory and compliance professionals – those who are dedicated to ensuring that regulation works.   Read More

Labeling Your Health

By Mit Spears  |    July 26, 2012
A physician, equipped with the latest medical and scientific information, prescribes a medicine as the best course of treatment for a patient. The patient follows the doctor's orders, takes the...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates